X4 Pharmaceuticals (XFOR) - Earnings growth in current year

Corporate emblem and logo of X4 Pharmaceuticals, Inc. (XFOR)

Risks for X4 Pharmaceuticals (XFOR) are linked to the limited market for orphan drugs and R&D expenditures. The 12-month relative EPS growth indicator in the daily price action on the GURU.Markets chart helps track these trends, where the value remains at 66.30. The business relies on outsourced manufacturing and clinics, generating revenue from the sale of a patented drug for the treatment of leukocyte deficiency.

XFOR - X4 Pharmaceuticals Earnings growth in current year over the range 07/04/2022 - 11/12/2026

Analytical breakdowns for X4 Pharmaceuticals

- price and consensus price forecast:
Stock Quotes X4 Pharmaceuticals Inc.|XFOR - Consensus Target
- market capitalization indicators:
Market Capitalization X4 Pharmaceuticals, Inc|XFOR - Total Company Value
- book capitalization data:
Equity per Share X4 Pharmaceuticals|XFOR - Book Capitalization|Market-to-Book Ratio x4pharma.com|XFOR - Cumulative Company Assets
- debt and liquidity details:
Debt to Equity Ratio X4 Pharmaceuticals|XFOR - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio x4pharma.com|XFOR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio X4 Pharmaceuticals, Inc|XFOR - Long-Term Liabilities|Company Short-Term Debts X4 Pharmaceuticals|Quick Ratio x4pharma.com
- earnings and market ratios statistics:
XFOR - Net Profit|Expected Profit X4 Pharmaceuticals|XFOR - Company Value to Net Income|Future Price to Earnings X4 Pharmaceuticals, Inc|XFOR - Price/Earnings to Growth Multiple|EV/EBITDA Multiple X4 Pharmaceuticals, Inc|XFOR - Operating profit EBITDA|Net earnings per share (EPS TTM) X4 Pharmaceuticals|XFOR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth x4pharma.com|XFOR - Earnings per share growth rate in current year|Expected earnings per share growth for next year X4 Pharmaceuticals
Analysis of all company metrics:X4 Pharmaceuticals Inc., XFOR
Brand item of X4 Pharmaceuticals, Inc.

This indicator measures the year-over-year growth rate of earnings per share, allowing for an assessment of the business's actual efficiency. Growth in this value confirms the ability of X4 Pharmaceuticals (XFOR) to generate additional free cash flow. The EPS dynamics compared to last year clearly reflect the monetization of exclusive rights to the drug for the treatment of WHIM syndrome. The high margins of this protected niche should translate into a positive trend for the metric, which minimizes the risk of overpaying for the asset.

Competitors of X4 Pharmaceuticals

Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|GRFS: Net earnings per share growth this year|ADPT (Adaptive Biotechnologies Inc.) - Earnings per share growth this year|Earnings per share growth this year Celldex Therapeutics|Net earnings per share growth this year auriniapharma.com|BCRX - Earnings per share increase in current year|Earnings per share growth in current year VERA|DNTH - Earnings per share trend in current year|Earnings growth in current year Pharvaris Pharma (PHVS)|Earnings per share increase in current year AbCellera Biologics|Earnings growth in current year tourmalinebio.com TRML|Precigen - Earnings growth in current year|PHAR: Earnings per share growth in current year|Earnings per share increase in current year Nektar NKTR|UPB (Upstream Pharma) - Earnings per share growth in current year|Net earnings per share growth this year ZBIO|Earnings growth in current year immunome.com|Earnings growth in current year GOSS|Earnings growth in current year KalVista Pharma (KALV)|Septerna Corp - Net earnings per share growth this year|Earnings growth in current year Pieris Corp PVLA|SVRA (Savara Inc.) - Earnings per share growth rate in current year|rigel.com (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Net earnings per share growth this year Astria Therapeutics Inc|enGene Bio (ENGN) - Net earnings per one share growth for the current year|Earnings growth in current year RAPT Therapeutics Inc.|JBIO (Aerovate Therapeutics Inc) - Expected net earnings per share growth this year|Earnings growth in current year aclaristx.com (ACRS)|Kyverna Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc - Earnings growth in current year|VTYX: Earnings per share growth in current year|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|AVTX (avalotx.com) - Earnings per share growth in current year|ELDN: Expected net earnings per share growth this year|Net earnings per share growth this year Agenus, Inc. (AGEN)|Earnings per share growth this year Climb Bio, Inc. CLYM|Earnings growth in current year Zura Bio Ltd (ZURA)|aTyr Pharma, Inc. (ATYR) - Earnings per share trend in current year|Adagene Inc - Earnings per share growth in current year|IMA (Ikena Oncology, Inc.) - Earnings per share growth rate in current year|STTK: Earnings per share growth in current year|Earnings per share increase in current year equilliumbio.com EQ|CNTB (Connect Biopharma Holdings Limited) - Earnings per share growth in current year|Earnings per share trend in current year Immunic Therapeutics IMUX|Earnings growth in current year Atara Biotherapeutics Inc|InflaRx N.V. (IFRX) - Earnings per share increase in current year|Earnings growth in current year adicetbio.com (ACET)|Earnings growth in current year CELU (Celularity)|INmune Bio Corporation - Earnings per share growth in current year|Earnings per share increase in current year Barinthus Biotherapeutics (BRNS)|KZR: Earnings per share growth in current year|SABS (SAB Biotherapeutics, Inc.) - Net earnings per share growth this year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|ENLV (Enlivex Therapeutics Ltd) - Earnings growth in current year|Net earnings per share growth this year Q32 Bio Corp (QTTB)|GeoVax Labs, Inc. (GOVX) - Earnings per share increase in current year|Earnings growth in current year edesabiotech.com (EDSA)|Expected net earnings per share growth this year IBIO|Carisma Therapeutics Inc - Earnings per share growth in current year|XTLB: Net earnings per share growth this year|BOLT: Earnings per share growth in current year|HCWB (hcwbiologics.com) - Net earnings per share growth this year|Net earnings per share growth this year Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech Inc.) - Earnings growth in current year|Earnings per share growth in current year ADTX|Earnings per share growth this year GRI Bio Corp GRI|Earnings growth in current year XORTX Corp (XRTX)|HIND: Earnings per share growth rate in current year|REVB - Net earnings per share growth this year|Indaptus Therapeutics, Inc. (INDP) - Earnings per share growth this year|SCNI (Scinai Immunotherapeutics Ltd) - Earnings per share growth this year|CALI (calcimedica.com) - Net earnings per share growth this year|Affimed N.V. - Earnings per share increase in current year|Earnings per share growth in current year Allakos Inc|HOOKIPA - Earnings per share trend in current year|Earnings growth in current year IGMS|ITOS (iTeos Therapeutics Inc) - Earnings per share increase in current year|Earnings growth in current year OCEA (Ocean Bio)|Earnings growth in current year TC BioPharm Ltd TCBP|THRD - Earnings per share growth in current year